Abstract
The optimal approach regarding breast cancer screening for Chinese women is unclear due to the relative low incidence rate. A risk assessment tool may be useful for selection of high-risk subsets of population for mammography screening in low-incidence and resource-limited developing country. The odd ratios for six main risk factors of breast cancer were pooled by review manager after a systematic research of literature. Health risk appraisal (HRA) model was developed to predict an individual’s risk of developing breast cancer in the next 5 years from current age. The performance of this HRA model was assessed based on a first-round screening database. Estimated risk of breast cancer increased with age. Increases in the 5-year risk of developing breast cancer were found with the existence of any of included risk factors. When individuals who had risk above median risk (3.3 ‰) were selected from the validation database, the sensitivity is 60.0 % and the specificity is 47.8 %. The unweighted area under the curve (AUC) was 0.64 (95 % CI = 0.50–0.78). The risk-prediction model reported in this article is based on a combination of risk factors and shows good overall predictive power, but it is still weak at predicting which particular women will develop the disease. It would be very helpful for the improvement of a current model if more population-based prospective follow-up studies were used for the validation.
Similar content being viewed by others
References
Chen XY, Kong ZL. Chinese Cancer Registry annual report 2009. Beijing: Military Medical Science Press; 2010. p. 26–8.
Huang ZZ, Chen WQ, Wu CX, Zheng RS, Chen JG, Yang NN, et al. Incidence and mortality of female breast cancer in China—a report from 32 Chinese cancer registries 2003–2007. Tumor. 2012;32(6):435–9.
Chen WQ, Zheng RS, Zeng HM, Zhang SW, Li GL, Wu LY, et al. Incidence and mortality of breast cancer in China, 2008. Thorac Cancer. 2013;4(1):59–65.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
Hillner BE. Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women. Evid Based Med. 2007;12(3):71.
Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer. 1996;66(6):727–31.
Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years—update of mortality results in the Stockholm Mammographic Screening trial. Breast Cancer Res Treat. 1997;45(3):263–70.
Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use. Am J Public Health. 1999;89(6):924–6.
Yip CH, Anderson BO. The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther. 2007;7(8):1095–104.
Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86.
Challa VR, Swamyvelu K, Shetty N. Assessment of the clinical utility of the Gail model in estimating the risk of breast cancer in women from the Indian population. Ecancermedicalscience. 2013;7:363.
Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res. 2012;14(6):R144.
Banegas MP, Gail MH, LaCroix A, Thompson B, Martinez ME, Wactawski-Wende J, et al. Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat. 2012;132(1):347–53.
WL Beery and National Center for Health Services Research and Health Care Technology Assessment (U.S.). Health risk appraisal: methods and programs, with annotated bibliography. Rockville, MD.: U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Services Research and Health Care Technology Assessment, 1986
Schoenbach VJ, Wagner EH, Karon JM. The use of epidemiologic data for personal risk assessment in health hazard/health risk appraisal programs. J Chronic Dis. 1983;30(9):625–38.
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 2013;25(1):10–21.
Fang JQ. Health statistics. Beijing: People’s Medical Publishing House; 2003. p. 313.
Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118,964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141–51.
Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250–63.
Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, et al. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the Shanghai Breast Cancer study. Am J Epidemiol. 2011;174(6):661–71.
Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst. 2010;102(21):1618–27.
Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013;25(5):368–87.
Aguilar Cordero MJ, Gonzalez Jimenez E, Alvarez Ferre J, Padilla Lopez CA, Mur Villar N, Garcia Lopez PA, et al. Breast feeding: an effective method to prevent breast cancer. Nutr Hosp. 2010;25(6):954–8.
Pan H, He Z, Ling L, Ding Q, Chen L, Zha X, et al. Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies. Cancer Epidemiol. 2013. doi:10.1016/j.canep.2013.11.004.
Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case–control and a case–case comparison. Breast Cancer Res. 2006;8(4):R39.
Huang Y, Zhang X, Li W, Song F, Dai H, Wang J, et al. A meta-analysis of the association between induced abortion and breast cancer risk among Chinese females. Cancer Causes Control. 2014;25(2):227–36.
Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132(2):365–77.
LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997;337(8):536–42.
Evans DG, Howell A. Breast cancer risk-assessment models. Breast Cancer Res. 2007;9(5):213.
Engelhardt EG, Garvelink MM, de Haes JH, van der Hoeven JJ, Smets EM, Pieterse AH, et al. Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models. J Clin Oncol. 2014;32(3):238–50.
Arrospide A, Forne C, Rue M, Tora N, Mar J, Bare M. An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain. BMC Cancer. 2013;13(1):587.
Gao F, Machin D, Chow KY, Sim YF, Duffy SW, Matchar DB, et al. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). BMC Cancer. 2012;12:529.
Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, et al. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst. 2007;99(22):1695–705.
Chay WY, Ong WS, Tan PH, Jie Leo NQ, Ho GH, Wong CS, et al. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res. 2012;14(1):R19.
Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H, et al. Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res. 2012;14(1):R17.
Von Euler-Chelpin M, Olsen AH, Njor S, Jensen A, Vejborg I, Schwartz W, et al. Does educational level determine screening participation? Eur J Cancer Prev. 2008;17(3):273–8.
Woloshin S, Schwartz LM. The U.S. Postal Service and cancer screening—stamps of approval? N Engl J Med. 1999;340(11):884–7.
Kye SY, Park K, Park HG, Kim MH. Psychological impact of health risk appraisal of Korean women at different levels of breast cancer risk: neglected aspect of the web-based cancer risk assessment tool. Asian Pac J Cancer Prev. 2012;13(2):437–41.
Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull. 2010;57(9):B4184.
Gaston-Johansson F, Ohly KV, Fall-Dickson JM, Nanda JP, Kennedy MJ. Pain, psychological distress, health status, and coping in patients with breast cancer scheduled for autotransplantation. Oncol Nurs Forum. 1999;26(8):1337–45.
Acknowledgments
This study was supported by the National Natural Science Foundation (Grants No. 81301799) and Tianjin Science and Technology Committee Foundation (Grants No. 11ZCGYSY02200). There are no financial interests associated with this work.
Conflict of interest
None
Disclosures
The experiments described in this study comply with the current laws of our country.
Open access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wang, Y., Gao, Y., Battsend, M. et al. Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women. Tumor Biol. 35, 10861–10869 (2014). https://doi.org/10.1007/s13277-014-1967-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-1967-0